CONTINUOUS AND FIXED-CYCLE DOSING OF INTRAVENOUS EFGARTIGIMOD FOR GENERALIZED MYASTHENIA GRAVIS: STUDY DESIGN OF ADAPT NXT

被引：0

作者：

Sahagian, Gregory ^{[1
]}

Hussain, Yessar ^{[2
]}

Feinberg, Marc H. ^{[3
]}

Habib, Ali A. ^{[4
]}

Skripuletz, Thomas ^{[5
]}

Ruck, Tobias ^{[6
]}

Brauer, Edward ^{[7
]}

Gelinas, Deborah ^{[7
]}

Liu, Li ^{[7
]}

Podhorna, Jana ^{[7
]}

Mantegazza, Renato ^{[8
]}

机构：

[1] Neurol Ctr Southern Calif, Carlsbad, CA USA

[2] Austin Neuromuscular Ctr, Austin, TX USA

[3] South Florida Neurol Associates, Boca Raton, FL USA

[4] Univ Calif Irvine, Dept Neurol, Irvine, CA USA

[5] Hannover Med Sch, Hannover, Germany

[6] Heinrich Heine Univ, Dept Neurol, Fac Med, Dusseldorf, Germany

[7] argenx, Ghent, Belgium

[8] Fdn IRCCS Ist Neurol Carlo Besta, Dept Neuroimmunol & Neuromuscular Dis, Milan, Italy

来源：

MUSCLE & NERVE | 2022年 / 65卷

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：S14 / S14

页数：1

共 50 条

[21] Randomized phase 2 study of FcRn antagonist efgartigimod in generalized myasthenia gravis
Howard, James F., Jr.
Bril, Vera
Burns, Ted M.
Mantegazza, Renato
Bilinska, Malgorzata
Szczudlik, Andrzej
Beydoun, Said
De Rivera Garrido, Francisco Javier Rodriguez
Piehl, Fredrik
Rottoli, Mariarosa
Van Damme, Philip
Tuan Vu
Evoli, Amelia
Freimer, Miriam
Mozaffar, Tahseen
Ward, E. Sally
Dreier, Torsten
Ulrichts, Peter
Verschueren, Katrien
Guglietta, Antonio
de Haard, Hans
Leupin, Nicolas
Verschuuren, Jan J. G. M.
Claeys, Kristl
Diez-Tejedor, Exuperio
Mathew, Veena
Sgarzi, Manlio
Harvey, Brittany Leigh
Farias, Jerrica
Frangiomore, Rita
Heintzman, Sarah
de Meel, Robert
Chopra, Manisha
Alboini, Paolo Emilio
Hietala, Albert
Genge, Angela
NEUROLOGY, 2019, 92 (23) : E2661 - E2673
[22] Long-Term Safety, Tolerability, And Efficacy of Efgartigimod in Patients with Generalized Myasthenia Gravis: Concluding Analyses from the ADAPT plus Study
Pasnoor, Mamatha
Bril, Vera
Karam, Chafic
Peric, Stojan
De Bleecker, Jan
Murai, Hiroyuki
Meisel, Andreas
Beydoun, Said
Vu, Tuan
Ulrichts, Peter
Van Hoorick, Benjamin
T'joen, Caroline
Utsugisawa, Kimiaki
Verschuuren, Jan
Mantegazza, Renato
Howard, James
NEUROLOGY, 2023, 100 (17)
[23] Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study
Bril, Vera
Howard Jr, James F.
Karam, Chafic
De Bleecker, Jan L.
Murai, Hiroyuki
Utsugisawa, Kimiaki
Ulrichts, Peter
Brauer, Edward
Zhao, Sihui
Mantegazza, Renato
Vu, Tuan
EUROPEAN JOURNAL OF NEUROLOGY, 2024, 31 (01)
[24] Long-term safety, tolerability, and efficacy of efgartigimod in patients with generalized myasthenia gravis: Concluding analyses from the ADAPT plus study
Bril, Vera
Pasnoor, Mamatha
Karam, Chafic
Peric, Stojan
De Bleecker, Jan L.
Murai, Hiroyuki
Meisel, Andreas
Beydoun, Said
Vu, Tuan
Ulrichts, Peter
Van Hoorick, Benjamin
T'Joen, Caroline
Kaprielian, Roger
Utsugisawa, Kimiaki
Verschuuren, Jan
Mantegazza, Renato
Howard, James F., Jr.
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2023, 455
[25] Long-term safety, tolerability, and efficacy of Efgartigimod in patients with Generalized Myasthenia Gravis: concluding analyses from the ADAPT plus study
Ashcraft, E.
Bril, V.
Pasnoor, M.
Karam, C.
Peric, S.
De Bleecker, J.
Murai, H.
Meisel, A.
Beydoun, S.
Vu, T.
Ulrichts, P.
Van Hoorick, B.
T'joen, C.
Utsugisawa, K.
Verschuuren, J.
Mantegazza, R.
Howard, J.
NEUROMUSCULAR DISORDERS, 2023, 33 : S179 - S179
[26] Efgartigimod for generalized myasthenia gravis: A multicenter real-world cohort study in China
Luo, Sushan
Jiang, Qilong
Zeng, Wenshuang
Wang, Qinzhou
Zou, Zhangyu
Yu, Yanyan
Hong, Daojun
Zeng, Quantao
Tan, Song
Zhang, Zhouao
Zhang, Yong
Guo, Xiuming
Chen, Jing
Zhao, Zhongyan
Huang, Shixiong
Shi, Jianquan
Chen, Ying
Du, Lei
Yan, Chong
Xi, Jianying
Song, Jie
Zhao, Chongbo
ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2024, 11 (08): : 2212 - 2221
[27] EFGARTIGIMOD IN GENERALIZED MYASTHENIA GRAVIS: A MULTICENTER REAL-WORLD COHORT STUDY IN CHINA
Luo, Sushan
Jiang, Qilong
Zeng, Wenshuang
Wang, Qinzhou
Zou, Zhangyu
Yu, Yanyan
Hong, Daojun
Zeng, Quantao
Tan, Song
Zhang, Zhouao
Zhang, Yong
Guo, Xiuming
Chen, Jing
Zhao, Zhongyan
Huang, Shixiong
Shi, Jianquan
Chen, Ying
Du, Lei
Zhao, Chongbo
Song, Jie
Yan, Chong
Xi, Jianying
MUSCLE & NERVE, 2024, 70 (03) : 563 - 563
[28] EFFICACY, SAFETY, AND TOLERABILITY OF EFGARTIGIMOD IN ACETYLCHOLINE RECEPTOR AUTOANTIBODY SERONEGATIVE PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTEGRATED INTERIM ANALYSIS OF THE ADAPT AND ADAPT plus STUDIES
Howard, James F., Jr.
Bril, Vera
Tuan Vu
Karam, Chafic
Peric, Stojan
De Bleecker, Jan L.
Murai, Hiroyuki
Pasnoor, Mamatha
Sacca, Francesco
Meisel, Andreas
Guglietta, Antonio
T'joen, Caroline
Utsugisawa, Kimiaki
Verschuuren, Jan
Mantegazza, Renato
MUSCLE & NERVE, 2022, 65 : S13 - S14
[29] EFFICACY, SAFETY, AND TOLERABILITY OF EFGARTIGIMOD IN ANTI-ACETYLCHOLINE RECEPTOR AUTOANTIBODY SERONEGATIVE PATIENTS WITH GENERALIZED MYASTHENIA GRAVIS: INTEGRATED INTERIM ANALYSIS OF ADAPT/ADAPT
Vu, Tuan
Bril, Vera
Karam, Chafic
Peric, Stojan
De Bleecker, Jan
Murai, Hiroyuki
Pasnoor, Mamatha
Sacca, Francesco
Meisel, Andreas
Guglietta, Antonio
T'joen, Caroline
Utsugisawa, Kimiaki
Mantegazza, Renato
Howard, James
MUSCLE & NERVE, 2022, 66 : S54 - S55
[30] LONG-TERM ASSESSMENT OF EFGARTIGIMOD IN PATIENTS WITH GENERALISED MYASTHENIA GRAVIS: ADAPT plus STUDY INTERIM RESULTS
Jacob, Saiju
Howard, James
Bril, Vera
Peric, Stojan
De Bleecker, Jan
T'joen, Carolin
Travers, Jackalyne
Utsugisawa, Kimiaki
Verschuuren, Jan
Mantegazza, Renato
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2022, 93 (09):

← 1 2 3 4 5 →